EBRT
Sponsors
Universitätsmedizin Mannheim, Noxopharm Limited, The Netherlands Cancer Institute, Akeso, Fudan University
Conditions
Endometrial CancerLocally Advanced Cervical CancerLocally Advanced Cervical CarcinomaMetastasisMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsProstatic Neoplasm
Phase 1
A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
TerminatedNCT04957290
Start: 2021-10-25End: 2023-06-07Updated: 2024-06-18
EBRT + Lu-PSMA for N1M0 Prostate Cancer
CompletedNCT05162573
Start: 2021-12-20End: 2025-09-09Updated: 2025-12-10
Phase 2
Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation
Not yet recruitingNCT05489848
Start: 2022-08-20End: 2030-08-20Target: 294Updated: 2022-08-05
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
RecruitingNCT05687851
Start: 2022-12-29End: 2026-12-31Target: 33Updated: 2024-09-19
Phase 3
Kypho-IORT vs. EBRT in Spinal Metastases
TerminatedNCT02773966
Start: 2017-11-12End: 2020-03-06Updated: 2022-07-22
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
Active, not recruitingNCT05235516
Start: 2022-06-21End: 2029-05-31Target: 636Updated: 2024-08-13